STERIS Operating Income increased by 2.8% to $273.20M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 11.4%, from $245.30M to $273.20M. Over 3 years (FY 2022 to FY 2025), Operating Income shows an upward trend with a 22.0% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Higher operating income indicates strong operational efficiency and pricing power, while a decline suggests rising costs or weakening demand.
Operating income is the profit realized from a company's core business operations after deducting all operating expenses...
A standard benchmark for operational performance; peers are compared based on operating margin percentages.
operating_income| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $14.32M | $116.50M | $202.93M | $144.06M | $158.40M | -$306.42M | $190.80M | $748.32M | $197.76M | $191.55M | $226.47M | $220.33M | $185.50M | $219.70M | $245.30M | $216.14M | $246.00M | $265.80M | $273.20M |
| QoQ Change | — | +713.3% | +74.2% | -29.0% | +10.0% | -293.4% | +162.3% | +292.2% | -73.6% | -3.1% | +18.2% | -2.7% | -15.8% | +18.4% | +11.7% | -11.9% | +13.8% | +8.0% | +2.8% |
| YoY Change | — | — | — | — | >999% | -363.0% | -6.0% | +419.5% | +24.9% | +162.5% | +18.7% | -70.6% | -6.2% | +14.7% | +8.3% | -1.9% | +32.6% | +21.0% | +11.4% |
| Segment | Q2 '23 | Q3 '23 | Q4 '23 | Q2 '24 | Q3 '24 | Q4 '24 | Q3 '25 | Q4 '25 |
|---|---|---|---|---|---|---|---|---|
| Segment operating income | $265.74M | $278.10M | $304.23M | $285.44M | $294.50M | $320.00M | $337.10M | $343.10M |
| Applied Sterilization Technologies | $109.59M | $110.78M | $105.16M | $117.71M | $109.90M | $115.80M | $127.60M | $129.20M |
| Corporate | -$91.87M | -$87.02M | -$81.56M | -$101.75M | -$97.10M | -$100.80M | -$109.90M | -$106.00M |
| Life Sciences: | — | — | — | — | — | — | $59.90M | $61.80M |
| Dental | $22.04M | $24.52M | $18.29M | — | — | — | — | — |
| Healthcare [Member] | $198.18M | $204.05M | $223.90M | $216.89M | $228.01M | $246.92M | — | — |
| Life Science Member | $49.84M | $50.28M | $56.74M | $52.58M | $53.70M | $58.13M | — | — |
| Total | $197.76M | $191.55M | $226.47M | $185.50M | $219.70M | $245.30M | $265.80M | $273.20M |
Dental, Healthcare [Member], Life Science Member were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.